Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline

Impaired diffusing capacity of the lung for carbon monoxide (DLCO) was frequently observed in systemic sclerosis (SSc) patients, generally related to the presence of interstitial lung disease (ILD) and/or pulmonary arterial hypertension (PAH). However, in clinical practice abnormally low DLCO values...

Celý popis

Podrobná bibliografie

Hlavní autoři:	M. Colaci, D. Giuggioli, M. Sebastiani, A. Manfredi, F. Lumetti, F. Luppi, S. Cerri, C. Ferri
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	PAGEPress Publications 2016-05-01
Edice:	Reumatismo
Témata:	Scleroderma systemic sclerosis DLCO pulmonary arterial hypertension lung fibrosis.
On-line přístup:	http://www.reumatismo.org/index.php/reuma/article/view/837
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!